Retour sur lavenir.net
   AB INBEV 69.200 € (0,00 %)     UMICORE 20.080 € (+0,30 %)     XIOR 27.550 € (+0,55 %)     ARGENX SE 791.800 € (-0,63 %)     ELIA GROUP 135.800 € (+0,30 %)     UCB 251.100 € (+0,44 %)     SOLVAY 25.940 € (-0,61 %)     SHURGARD 26.550 € (+1,14 %)     JENSEN-GROUP 80.600 € (-1,23 %)     VASTNED 29.850 € (+2,05 %)     MONTEA 67.900 € (+1,65 %)     SIPEF 90.200 € (+0,22 %)     BARCO 8.360 € (-0,71 %)     D'IETEREN GROUP 172.100 € (+0,76 %)     NYXOAH 1.508 € (+0,40 %)     SYENSQO 65.800 € (+0,30 %)     AGEAS 71.400 € (+0,56 %)     KBC 120.350 € (+0,75 %)     MELEXIS 72.050 € (-7,45 %)     PROXIMUS 5.935 € (+1,45 %)     AEDIFICA 69.800 € (+0,79 %)     CAMPINE 213.000 € (-0,47 %)     ATENOR 1.590 € (-0,62 %)     IBA 16.740 € (+0,12 %)     SOFINA 227.800 € (+0,80 %)     TUBIZE-FIN 219.000 € (-0,09 %)     ASCENCIO 51.800 € (+0,19 %)     DEME GROUP 169.000 € (0,00 %)     CELYAD ONCOLOGY 0.229 € (-1,29 %)     CENERGY 22.240 € (+1,46 %)     QUESTFOR GR-PRICAF 2.920 € (-1,02 %)     ACKERMANS V.HAAREN 268.600 € (-0,30 %)     BEKAERT 39.800 € (+0,38 %)     GIMV 44.700 € (-0,11 %)     TESSENDERLO 20.100 € (+1,01 %)     RETAIL ESTATES 68.600 € (+0,29 %)     AZELIS GROUP 9.980 € (+0,81 %)     ONTEX GROUP 2.240 € (+1,59 %)     KINEPOLIS GROUP 36.250 € (+1,12 %)     WDP 22.000 € (+0,82 %)     TINC 11.340 € (+0,35 %)     GBL 78.100 € (0,00 %)     BREDERODE 104.000 € (-0,38 %)     BPOST 1.608 € (0,00 %)     CMB.TECH 13.040 € (+0,31 %)     TITAN S.A. 50.400 € (+0,60 %)     LOTUS BAKERIES 11 180.000 € (-1,24 %)     KBC ANCORA 83.800 € (+0,36 %)     ECONOCOM GROUP 1.450 € (+2,84 %)     VGP 82.400 € (+0,86 %)     CIE BOIS SAUVAGE 305.000 € (+1,33 %)     ONWARD MEDICAL 2.523 € (+0,90 %)     EVS 27.100 € (+0,37 %)     HOME INVEST BE. 19.160 € (+0,74 %)     RECTICEL 11.320 € (+1,07 %)     CARE PROPERTY INV. 12.640 € (0,00 %)     FAGRON 23.950 € (0,00 %)     AGFA-GEVAERT 0.416 € (-0,95 %)     COLRUYT 36.840 € (+0,66 %)     HYBRID SOFTWARE GR 3.960 € (+1,54 %)  
   74SOFTWARE 36.100 € (+0,56 %)     STIF 52.050 € (+0,10 %)     PLANISWARE 20.900 € (+1,95 %)     FDJ UNITED 22.900 € (-0,35 %)     CAPGEMINI 89.940 € (+1,06 %)     SOCIETE GENERALE 73.600 € (+0,53 %)     AIRBUS 195.040 € (-0,75 %)     CROSSJECT 1.654 € (+0,24 %)     J.MARTINS,SGPS 16.210 € (-1,58 %)     NN GROUP 76.630 € (+0,25 %)     Vusion 137.200 € (+2,46 %)     VINCI 119.600 € (+0,21 %)     HEINEKEN 75.080 € (+0,16 %)     WOLTERS KLUWER 61.040 € (+1,87 %)     EGIDE 1.014 € (-1,55 %)     ASML HOLDING 1 566.800 € (-2,25 %)     SAFRAN 336.700 € (-0,97 %)     L'OREAL 379.400 € (-0,07 %)     AIR LIQUIDE 173.020 € (+0,03 %)     SHELL PLC 35.720 € (-0,06 %)     ING GROEP N.V. 28.410 € (-0,07 %)     ORANGE 15.890 € (+0,16 %)     GENFIT 13.920 € (+1,02 %)     ERAMET 44.200 € (+0,78 %)     ENGIE 26.930 € (-0,63 %)     VIVORYON 1.410 € (-4,41 %)     ADYEN 844.500 € (+1,20 %)     UBISOFT ENTERTAIN 5.952 € (+1,36 %)     MAUREL ET PROM 7.810 € (-1,33 %)     LVMH 492.150 € (-0,16 %)     LISI 66.300 € (-1,19 %)     ESSILORLUXOTTICA 172.700 € (+0,61 %)     OVH 14.770 € (-3,15 %)     MAGNUM 16.100 € (+1,09 %)     STMICROELECTRONICS 62.310 € (-0,59 %)     HERMES INTL 1 638.000 € (+0,83 %)     TELEPERFORMANCE 51.860 € (+3,18 %)     SARTORIUS STED BIO 185.600 € (+3,34 %)     NOS, SGPS 4.884 € (+0,04 %)     CTP 16.580 € (+0,97 %)     OSE IMMUNO 3.394 € (-0,41 %)     ALSTOM 15.795 € (+1,06 %)     GECINA 71.950 € (+3,15 %)     PHILIPS KON 24.040 € (+0,50 %)     RUBIS 31.420 € (-0,32 %)     BNP PARIBAS ACT.A 100.440 € (+0,62 %)     PROSUS 39.755 € (+0,20 %)     EUROFINS SCIENT. 69.540 € (+1,08 %)     VEOLIA ENVIRON. 36.330 € (-0,52 %)     SAINT GOBAIN 75.180 € (+1,16 %)     B.COM.PORTUGUES 1.043 € (+0,48 %)     SCHNEIDER ELECTRIC 268.950 € (-0,39 %)     ABN AMRO BANK N.V. 38.140 € (-0,29 %)     CSG 13.562 € (+0,38 %)     KERING 246.250 € (+0,18 %)     KPN KON 4.256 € (+0,71 %)     ARCELORMITTAL SA 57.680 € (+5,80 %)     ACCOR 48.950 € (+0,60 %)     WORLDLINE 10.230 € (+3,03 %)     CREDIT AGRICOLE 17.455 € (+0,17 %)  
News Réglementées
10/07/2026 10:00

REPLOID research project 'Opti2Fly' receives funding from the German Federal Ministry for Research, Technology and Space


EQS-Media / 10.07.2026 / 10:00 CET/CEST

PRESS RELEASE

REPLOID research project "Opti2Fly" receives funding from the German Federal Ministry for Research, Technology and Space

  • €850,000 in federal funding for a research project under the KMU-innovativ program
  • REPLOID leads consortium including TU Dresden and Max Planck Institute for Evolutionary Biology
  • Goal is to develop an AI-powered platform for the automated quality assessment of living larvae for the REPLOID breeding program

 

WELS, Austria – July 10, 2026 – REPLOID Group AG ("REPLOID") has been awarded funding by the German Federal Ministry of Research, Technology and Space (BMFTR) under the KMU-innovativ initiative. The research and development project "Opti2Fly" has a total project volume of €1.1 million, with the federal government supporting the planned research activities with €850,000.

REPLOID offers an innovative system for the industrial processing of regional organic residues from the food industry – using larvae of the Black Soldier Fly. These residues are converted into valuable raw materials, including proteins, high-quality fats, and organic fertilizer.

Research and development is a cornerstone of REPLOID's business model. At the Global Innovation Center in Leipzig (Germany) an interdisciplinary team continuously works to improve the Black Soldier Fly's bioconversion process – from feed formulations and high-performance larval strains to marketable end products.

The research project "Opti2Fly" is a prime example of REPLOID's sustained investment in its own research capabilities. The project centers on developing an innovative analytics platform that combines state-of-the-art measurement technology with artificial intelligence methods. The goal is to capture key quality and performance characteristics of living larvae. The findings will directly advance the REPLOID breeding program and further optimize the overall bioconversion process.

REPLOID leads the research consortium alongside renowned partners, including TU Dresden, which provides validated reference measurements and the Max Planck Institute for Evolutionary Biology, which is responsible for the biological characterization of the breeding material.

Jonas Finck, COO of REPLOID: "This funding commitment confirms that we are on the right track: our research is convincing, also on the highest level. We are proud that we were able to prevail against strong competition in today’s very challenging funding environment. It shows that we are not only asking the right questions, but also delivering compelling answers."

The project results are expected to feed directly into REPLOID's production operations in the medium term, further strengthening the company's position as a leading technology provider in insect farming.

 

 

About REPLOID Group AG

REPLOID offers an innovative system for the industrial utilization of regional organic residues from the food industry.

The company builds and services modular and scalable insect-rearing plants for its customers – the REPLOID ReFarmUnits. In these plants, young Black Soldier Fly larvae supplied by the company receive a site-specific feed mix. This mix is developed on the basis of REPLOID’s own research and development using residual materials from the regional food value chain. After rearing, customers either use the larvae and/or their by-products themselves, or REPLOID takes them back for centralized marketing or further processing.

REPLOID sells the reared larvae either directly or, after further processing into proteins and fats, for example, to customers in the animal feed industry. From the by-products of insect rearing (insect frass), the company produces premium organic fertilizer.

With decentralized upcycling on an industrial scale, REPLOID provides an economically attractive solution within the circular economy. Food residues and unused food are utilized efficiently, helping to conserve key resources over the long term.

REPLOID Group AG was founded in 2020 and is headquartered in Wels, Austria. The company has a global focus and has been listed since July 2025 on the Vienna Stock Exchange’s direct market plus segment (ticker symbol: HRX5). The Group employs more than 135 people.

Contact

Hans Lang | Director Group Communications | +43 660 693 45 63 | presse@reploid.eu



End of Media Release


Issuer: REPLOID Group AG
Key word(s): Research/Technology

10.07.2026 CET/CEST This Press Release was distributed by EQS Group

View original content: EQS News


Language:English
Company:REPLOID Group AG
Durisolstraße 6
4600 Wels
Austria
Phone:+43 660 / 776 50 40
E-mail:office@reploid.eu
Internet:reploid.eu
ISIN:AT0000A3HRX5
Listed:Vienna Stock Exchange (Vienna MTF)
EQS News ID:2363792

 
End of NewsEQS Media

2363792  10.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière